Picture of Cytosorbents logo

CTSO Cytosorbents Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapMomentum Trap

Annual balance sheet for Cytosorbents, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
R2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments52.122.114.13.286.25
Net Total Accounts Receivable
Net Total Receivables4.525.666.067.327.55
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets64.333.825.421.620.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment18.623.322.120.518.7
Net Intangible Assets
Other Long Term Assets
Total Assets89.563.25347.444.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities13.79.71149.829.71
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities26.927.929.536.338.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity62.635.423.511.15.9
Total Liabilities & Shareholders' Equity89.563.25347.444.2
Total Common Shares Outstanding